Immunotherapy regimes dependent on ApoE status

Details for Australian Patent Application No. 2008311823 (hide)

Owner Janssen Alzheimer Immunotherapy Wyeth LLC

Inventors Black, Ronald; Gregg, Keith M.; Callaway, James; Gill, Davinder; Widom, Angela; Tchistiakova, Lioudmila; Lieberburg, Ivan; Ekman, Lars; Grundman, Michael; Jacobsen, Jack Steven

Agent Spruson & Ferguson

Pub. Number AU-A-2008311823

PCT Pub. Number WO2009/052439

Priority 61/083,827 25.07.08 US; 60/999,423 17.10.07 US

Filing date 17 October 2008

Wipo publication date 23 April 2009

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/052439 Priority application(s): WO2009/052439

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008311824-Inhibitors of anti-apoptotic proteins

2008311822-Devices for termination of tethers